You are here » Home » B2B Connect » B2B - Pharma
Eye check-up image via Shutterst

Sun Pharma buys US-based Ocular Technologies for $ 40 million

The acquisition of Ocular Technologies, which is developing Seciera for the treatment of Dry Eye Disease, will enhance Sun Pharma's specialty ...



Dr Reddy's partners Gland Pharma in the US to market injectables » More


What’s driving mergers and acquisitions in pharma industry? » More


Subscribe to the Business Standard b2b Connect Newsletters and stay updated with lastest news, features, events and more in key industries

Select one or more industry newsletters

Plastic & Polymers
All of the above

International News

BD to collaborate with Columbia Asia Hospitals for diabetes management » More


Role of the leadership to drive sustainability is critical: Jayakumar Krishnaswamy » More


Sustainable product design is not about public relations: Dr Mosongo Moukwa » More

Upgrade To Premium Services

Welcome User

Business Standard is happy to inform you of the launch of "Business Standard Premium Services"

As a premium subscriber you get an across device unfettered access to a range of services which include:

  • Access Exclusive content - articles, features & opinion pieces
  • Weekly Industry/Genre specific newsletters - Choose multiple industries/genres
  • Access to 17 plus years of content archives
  • Set Stock price alerts for your portfolio and watch list and get them delivered to your e-mail box
  • End of day news alerts on 5 companies (via email)
  • NEW: Get seamless access to at a great price. No additional sign-up required.

Premium Services

In Partnership with


Dear Guest,


Welcome to the premium services of Business Standard brought to you courtesy FIS.
Kindly visit the Manage my subscription page to discover the benefits of this programme.

Enjoy Reading!
Team Business Standard